IP Library Granted Patent US 7,576,214
Granted Patent B2
US 7,576,214 · App. 10/572,636 · Granted Aug 18, 2009

Process for preparing 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1, 4-dihydro-1,8-naphthyridine-3-carboxylic acid

Assignee: LG Life Sciences Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,576,214
App. No.
10/572,636
Granted
Aug 18, 2009
Kind
B2
Abstract

Starting from ethyl 3-(2,6-dichloro-5-fluoropyridin-3-yl)-3-oxo-propanoate (1), the present invention provides highly pure 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid (5) in one-pot four steps using a single solvent.

Claims (29)

1. A process for preparing 1,8-naphthyridine-3-carboxylic acid compound of the following formula (5)

in which

Y represents straight-chain, branched or cyclic alkyl, having 1 to 5 carbon atoms, and unsubstituted or substituted by halogen, said process comprising:

the first step a) the compound of the following formula (1),

is reacted with dimethylformamide dialkylacetal of formula Me 2 NCH(OR) 2 (wherein R represents straight-chain, branched or cyclic alkyl having 1 to 9 carbon atoms, or represents benzyl) in a solvent in the presence of acid catalyst to prepare the compound of the following formula (2),

the second step b) the resulting reaction mixture of the following formula (2),

is reacted with amine of formula YNH 2 to prepare the compound of the following formula (3),

in which

Y is defined as above,

the third step c) the resulting compound of the following formula (3),

in which

Y is as defined above,

is cyclized in the presence of quaternary ammonium salt and a base to prepare 1,8-naphthyridine-3-carboxylic acid ester of the following formula (4),

in which

Y is as defined above, and

in the fourth step d) the resulting compound of the following formula (4),

in which

Y is as defined above,

is hydrolyzed in the presence of an acid to prepare 1,8-naphthyridine-3-carboxylic acid compound of the said formula (5),

said process is characterized by a one pot operation of the above steps using a single solvent system without intermediate isolation.

2. The process according to claim 1 wherein R represents methyl.

3. The process according to claim 1 wherein the solvent used is toluene.

4. The process according to claim 1 wherein dimethylformamide dialkylacetal of formula [Me 2 NCH(OR) 2 ] is employed from 1.05 to 1.15 mole equivalents per mole of the compound of formula (1).

5. The process according to claim 1 wherein in the step a), acetic acid as acid catalyst is employed from 0.2 to 0.3 mole equivalents per mole of the compound of formula (1).

6. The process according to claim 1 wherein amine of formula YNH 2 is cyclopropylamine.

7. The process according to claim 1 wherein amine of formula YNH 2 is employed from 1.1 to 1.2 mole equivalents per mole of the compound of formula (1).

8. The process according to claim 1 wherein the reaction solution after the step b) is washed with aqueous citric acid solution.

9. The process according to claim 1 wherein in the step c), aqueous tetrabutylammonium hydroxide solution is used as base.

10. The process according to claim 1 wherein in the step d), the reaction solution is heated under reflux by using concentrated aqueous hydrochloric acid.

Assignments (2)
MERGER Recorded Sep 2, 2017
From: LG LIFE SCIENCES LTD.
To: LG CHEM, LTD.
Reel/Frame 043475/0619 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2006
From: SHIN, HYUN-IK; CHANG, JAY-HYOK; LEE, KYU-WOONG
To: LG LIFE SCIENCES LTD.
Reel/Frame 017677/0931 →
Priority Claims (1)
KR 10-2003-0075962 · Oct 29, 2003 · national
Continuity (1)
Related Publication 20070021613A1 · Jan 25, 2007